The correlation between high nuclear HIF-2α and shortened overall survival in the HER2 and hormone receptor positive patient sub-cohort may be due to the attenuated downregulation of HIF-2α upon E2 treatment in HER2 positive breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.